Published in Biochemistry on November 12, 1991
Protein-protein interactions: methods for detection and analysis. Microbiol Rev (1995) 5.08
Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses. Microbiol Rev (1996) 4.21
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci U S A (1994) 1.93
Hot-spot mimicry of a cytokine receptor by a small molecule. Proc Natl Acad Sci U S A (2006) 1.47
Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1992) 1.43
Glycoarrays with engineered phages displaying structurally diverse oligosaccharides enable high-throughput detection of glycan-protein interactions. Biotechnol J (2014) 1.38
A phage display system for studying the sequence determinants of protein folding. Protein Sci (1995) 1.36
Subtiligase: a tool for semisynthesis of proteins. Proc Natl Acad Sci U S A (1994) 1.33
High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci U S A (1994) 1.26
Borrelia burgdorferi adhesins identified using in vivo phage display. Mol Microbiol (2007) 1.17
Lambda foo: a lambda phage vector for the expression of foreign proteins. Proc Natl Acad Sci U S A (1994) 1.16
Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles. J Mol Biol (2011) 1.08
Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage. Nucleic Acids Res (1993) 1.02
Membrane insertion defects caused by positive charges in the early mature region of protein pIII of filamentous phage fd can be corrected by prlA suppressors. J Bacteriol (1994) 0.99
An improved helper phage system for efficient isolation of specific antibody molecules in phage display. Nucleic Acids Res (2002) 0.97
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proc Natl Acad Sci U S A (1996) 0.97
Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization. Proc Natl Acad Sci U S A (2003) 0.95
Production of an atrial natriuretic peptide variant that is specific for type A receptor. EMBO J (1994) 0.95
Investigation of antigen-antibody interactions using a soluble, non-support-bound synthetic decapeptide library composed of four trillion (4 x 10(12) sequences. Biochem J (1994) 0.90
Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma. Proc Natl Acad Sci U S A (1994) 0.89
Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system. Clin Diagn Lab Immunol (2003) 0.86
Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display. Protein Eng Des Sel (2010) 0.85
Antibody buffering of a ligand in vivo. Proc Natl Acad Sci U S A (2004) 0.84
Peptide ligands that use a novel binding site to target both TGF-β receptors. Mol Biosyst (2010) 0.82
Rapid preparation of stable isotope labeled peptides that bind to target proteins by a phage library system. J Biomol NMR (2006) 0.81
VHH phage-based competitive real-time immuno-polymerase chain reaction for ultrasensitive detection of ochratoxin A in cereal. Anal Chem (2014) 0.81
Tracking molecular recognition at the atomic level with a new protein scaffold based on the OB-fold. PLoS One (2014) 0.80
Isolation of peptides from phage-displayed random peptide libraries that interact with the talin-binding domain of vinculin. Biochem J (1997) 0.79
Phage display against corneal epithelial cells produced bioactive peptides that inhibit Aspergillus adhesion to the corneas. PLoS One (2012) 0.78
Direct measurement via phage titre of the dissociation constants in solution of fusion phage-substrate complexes. Nucleic Acids Res (1995) 0.78
Protein and Antibody Engineering by Phage Display. Methods Enzymol (2016) 0.78
DeltaPhage--a novel helper phage for high-valence pIX phagemid display. Nucleic Acids Res (2012) 0.77
Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein. Biotechnol Res Int (2011) 0.77
Display of functional beta-lactamase inhibitory protein on the surface of M13 bacteriophage. Antimicrob Agents Chemother (1998) 0.76
Quantitative PCR is a Valuable Tool to Monitor the Performance of DNA-Encoded Chemical Library Selections. Chembiochem (2017) 0.75
A hot spot of binding energy in a hormone-receptor interface. Science (1995) 10.41
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science (1989) 8.73
Convergent solutions to binding at a protein-protein interface. Science (2000) 4.47
Cloning, sequencing, and secretion of Bacillus amyloliquefaciens subtilisin in Bacillus subtilis. Nucleic Acids Res (1983) 3.70
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab (2001) 3.31
Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science (1991) 3.24
Dissecting the catalytic triad of a serine protease. Nature (1988) 3.19
In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry (1994) 3.18
Comparison of a structural and a functional epitope. J Mol Biol (1993) 3.12
Systematic mutational analyses of protein-protein interfaces. Methods Enzymol (1991) 2.95
Phage display for selection of novel binding peptides. Methods Enzymol (2000) 2.78
Site-directed ligand discovery. Proc Natl Acad Sci U S A (2000) 2.58
Rational design of potent antagonists to the human growth hormone receptor. Science (1992) 2.45
A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci U S A (1991) 2.43
Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid. Br J Haematol (1997) 2.27
Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell (1997) 2.24
Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Br Med J (1979) 2.23
Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites. Gene (1985) 2.15
Structural plasticity in a remodeled protein-protein interface. Science (1997) 2.05
Substrate phage: selection of protease substrates by monovalent phage display. Science (1993) 2.04
Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science (1989) 2.02
A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol (1994) 1.97
Hormone phage: an enrichment method for variant proteins with altered binding properties. Proteins (1990) 1.94
Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci U S A (1997) 1.91
Effects of calcitonin therapy in deafness associated with Paget's disease of bone. Br Med J (1974) 1.88
The prevalence of homosexual behavior and attraction in the United States, the United Kingdom and France: results of national population-based samples. Arch Sex Behav (1995) 1.86
Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature (1999) 1.86
Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. J Mol Biol (1998) 1.79
A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues. Science (1994) 1.79
Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J Cereb Blood Flow Metab (2000) 1.77
Minimizing a binding domain from protein A. Proc Natl Acad Sci U S A (1996) 1.75
Occupational stress and health among factory workers. J Health Soc Behav (1979) 1.72
Secretion and autoproteolytic maturation of subtilisin. Proc Natl Acad Sci U S A (1986) 1.72
In vitro selection from protein and peptide libraries. Trends Biotechnol (1994) 1.68
Engineering subtilisin and its substrates for efficient ligation of peptide bonds in aqueous solution. Biochemistry (1991) 1.66
Active site trapping of nucleotides by crosslinking two sulfhydryls in myosin subfragment 1. Proc Natl Acad Sci U S A (1979) 1.65
Diagnosis of low-lying placenta: can migration in the third trimester predict outcome? Ultrasound Obstet Gynecol (2001) 1.64
Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science (1990) 1.63
The fluorescent antibody tissue stain for Treponema pallidum in the eye. Am J Ophthalmol (1967) 1.59
Designing substrate specificity by protein engineering of electrostatic interactions. Proc Natl Acad Sci U S A (1987) 1.58
Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab (2000) 1.56
Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med (1995) 1.55
Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem (1998) 1.53
In vivo formation and stability of engineered disulfide bonds in subtilisin. J Biol Chem (1986) 1.51
Affinity maturation of human growth hormone by monovalent phage display. J Mol Biol (1993) 1.51
High resolution functional analysis of antibody-antigen interactions. J Mol Biol (1992) 1.49
Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology (1994) 1.49
The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain. J Biol Chem (1990) 1.43
Engineering an enzyme by site-directed mutagenesis to be resistant to chemical oxidation. J Biol Chem (1985) 1.43
Engineering enzyme specificity by "substrate-assisted catalysis". Science (1987) 1.43
Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level. Biochem J (1990) 1.41
Subtilisin--an enzyme designed to be engineered. Trends Biochem Sci (1988) 1.40
Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J Mol Biol (1997) 1.40
Probing steric and hydrophobic effects on enzyme-substrate interactions by protein engineering. Science (1986) 1.37
Subtiligase: a tool for semisynthesis of proteins. Proc Natl Acad Sci U S A (1994) 1.33
The role of lysine-234 in beta-lactamase catalysis probed by site-directed mutagenesis. Biochemistry (1990) 1.31
Recruitment of substrate-specificity properties from one enzyme into a related one by protein engineering. Proc Natl Acad Sci U S A (1987) 1.29
Structural mimicry of a native protein by a minimized binding domain. Proc Natl Acad Sci U S A (1997) 1.23
Reliability and validity of the PAS-ADD Checklist for detecting psychiatric disorders in adults with intellectual disability. J Intellect Disabil Res (1998) 1.21
Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci U S A (1991) 1.21
Long-acting growth hormones produced by conjugation with polyethylene glycol. J Biol Chem (1996) 1.19
Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site. Biochemistry (1998) 1.19
Minimization of a polypeptide hormone. Science (1995) 1.19
Functional interaction among catalytic residues in subtilisin BPN'. Proteins (1990) 1.17
Dimerization of human growth hormone by zinc. Science (1991) 1.16
Antibody humanization using monovalent phage display. J Biol Chem (1997) 1.15
Chemical modification of myosin by active-site trapping of metal-nucleotides with thiol crosslinking reagents. Methods Enzymol (1982) 1.15
Protein engineering of disulfide bonds in subtilisin BPN'. Biochemistry (1989) 1.15
Improvement in the alkaline stability of subtilisin using an efficient random mutagenesis and screening procedure. Protein Eng (1989) 1.13
Dissecting the energetics of an antibody-antigen interface by alanine shaving and molecular grafting. Protein Sci (1994) 1.13
Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC. J Mol Biol (1999) 1.13
A survey of furin substrate specificity using substrate phage display. Protein Sci (1994) 1.13
Engineering human prolactin to bind to the human growth hormone receptor. Science (1990) 1.12
How can adolescents' health needs and concerns best be met? Br J Gen Pract (1997) 1.12
High copy display of large proteins on phage for functional selections. J Mol Biol (2000) 1.11
An improved method for purifying 2',5'-oligoadenylate synthetases. J Biol Chem (1984) 1.11
Minimized proteins. Curr Opin Struct Biol (1997) 1.11
Selection for improved subtiligases by phage display. Proc Natl Acad Sci U S A (1999) 1.10
Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene. Ophthalmology (1994) 1.10
Probing the mechanism and improving the rate of substrate-assisted catalysis in subtilisin BPN'. Biochemistry (1991) 1.10
Acne vulgaris. BMJ (1994) 1.09
Designing subtilisin BPN' to cleave substrates containing dibasic residues. Biochemistry (1995) 1.08
Multicentric granulocytic sarcoma (chloroma) of the breast: mammographic findings. AJR Am J Roentgenol (1993) 1.07
Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates. Biochemistry (1996) 1.07
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756. Synapse (1999) 1.05
Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J Biol Chem (1995) 1.05
In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652. J Nucl Med (2000) 1.05
Structural and mutational analysis of affinity-inert contact residues at the growth hormone-receptor interface. Biochemistry (1996) 1.04
Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans. Neuropsychopharmacology (2001) 1.04
Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis. J Biol Chem (1998) 1.03
Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J Clin Invest (1992) 1.01
Mechanism-based design of prolactin receptor antagonists. J Biol Chem (1993) 1.00
Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology (1994) 0.99
Prevalence of obesity: a comparative survey in France, the United Kingdom and the United States. Int J Obes Relat Metab Disord (1992) 0.99
The influence of source of insurance coverage on the health care utilization patterns of the elderly. J Health Hum Resour Adm (1989) 0.98
Changes in glucose transporters in muscle in response to exercise. Am J Physiol (1989) 0.98
Antibiotics in acne: time for a rethink. Br J Dermatol (2001) 0.97
Conservation of caspase substrates across metazoans suggests hierarchical importance of signaling pathways over specific targets and cleavage site motifs in apoptosis. Cell Death Differ (2012) 0.97
Reaction of 5,5'-dithiobis(2-nitrobenzoic acid) with myosin subfragment one: evidence for formation of a single protein disulfide with trapping of metal nucleotide at the active site. Biochemistry (1980) 0.97